2014
DOI: 10.3389/fmicb.2014.00067
|View full text |Cite
|
Sign up to set email alerts
|

Generation of a vector suite for protein solubility screening

Abstract: Recombinant protein expression has become an invaluable tool for academic and biotechnological projects. With the use of high-throughput screening technologies for soluble protein production, uncountable target proteins have been produced in a soluble and homogeneous state enabling the realization of further studies. Evaluation of hundreds conditions requires the use of high-throughput cloning and screening methods. Here we describe a new versatile vector suite dedicated to the expression improvement of recomb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 35 publications
0
20
0
Order By: Relevance
“…Only three primers per candidate are required to clone each candidate gene into the vector suite: one forward primer to generate the His, His-TRX, His-MBP and His-TF fusion constructs, a second forward primer for the SUMO fusion constructs required to engineer the immediate transition from SUMO-tag to candidate protein, and a reverse primer which was used for all five (Additional file 1 : Table S4). Complementing a recent report [ 57 ], we demonstrated the application of RF-cloning in building a tailored vector suite and enabling parallel cloning of candidate sequences. All vectors were tested in the E. coli Rosetta2(DE3)pLysS strain for soluble expression of fusion partners without candidate genes, and as expected, the majority of recombinant proteins were soluble (data not shown).…”
Section: Resultsmentioning
confidence: 82%
“…Only three primers per candidate are required to clone each candidate gene into the vector suite: one forward primer to generate the His, His-TRX, His-MBP and His-TF fusion constructs, a second forward primer for the SUMO fusion constructs required to engineer the immediate transition from SUMO-tag to candidate protein, and a reverse primer which was used for all five (Additional file 1 : Table S4). Complementing a recent report [ 57 ], we demonstrated the application of RF-cloning in building a tailored vector suite and enabling parallel cloning of candidate sequences. All vectors were tested in the E. coli Rosetta2(DE3)pLysS strain for soluble expression of fusion partners without candidate genes, and as expected, the majority of recombinant proteins were soluble (data not shown).…”
Section: Resultsmentioning
confidence: 82%
“…However, the pyruvate oxidase activity of E. coli pET32a‐ pod was lower than that of E. coli pET28a ‐pod because of the fused tag was not universal for heterologous gene expression (Correa et al . ).…”
Section: Resultsmentioning
confidence: 97%
“…Correa et al . () constructed 12 vectors with different elements for high solubility heterologous protein screening because there was not a conclusion for a vector suitable to a heterologous protein without experiments. The same optimized temperature was used for the three recombinant E. coli strains because high temperature triggered extremely low soluble pyruvate oxidase.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Costa and coauthors give a thorough description of different fusion tags that can be appended to the target protein in order to increase its solubility and/or ease its purification from the cellular milieu (Costa et al, 2014). Along this line, Correa and coauthors present a very promising approach to straightforwardly assess the solubility of a recombinant protein by cloning the corresponding gene in 12 different expression vectors in parallel (Correa et al, 2014). Even though IB formation is mainly regarded as a nuance in the production of recombinant proteins, Ramon and coworkers make the case that this is not always true and focus on the positive side of IBs, highlighting the advantages of producing recombinant proteins as IBs for basic and applied research (Ramon et al, 2014).…”
Section: Current Status In Recombinant Protein Expression In Microbiamentioning
confidence: 99%